INVAInnoviva, Inc.

$1B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$54M+539.7% YoY

Gross Profit

$51M95.1% margin

Operating Income

$32M58.5% margin

Net Income

-$19M-34.8% margin

EPS (Diluted)

$-0.16

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$10M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$424M

Total Liabilities

$767M

Stockholders' Equity

-$343M

Cash & Equivalents

$159M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$8M	+539.7%
Gross Profit	$51M	$935,000	+5389.8%
Operating Income	$32M	-$34M	+193.1%
Net Income	-$19M	-$168M	+88.9%

INVA FY 2015 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena